Business Description
NephroGenex Inc
NAICS : 446110
SIC : 2834
ISIN : US6406671015
Compare
Compare
Traded in other countries / regions
IPO Date
2014-02-11Description
NephroGenex Inc. was incorporated in Delaware on May 25, 2004. It is a drug development company focused on developing novel therapies for kidney disease. The Company acquired commercial rights to Pyridorin and has initiated a Phase 3 clinical study in patients with diabetic nephropathy. It has developed Pyridorin, which has demonstrated preliminary evidence of efficacy in slowing the progression of diabetic nephropathy in relevant patient populations in three Phase 2 clinical studies. The Company is also researching on the application of an intravenous formulation of Pyridorin to specific types of AKI in patients at increased risk and where pathogenic oxidative chemistries have been identified as a possible contributing factor to the severity of this condition. Pyridorin is a drug candidate for diabetic nephropathy. The Company competes with other biotechnology and pharmaceutical companies.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -80 | |||||
| 12-1 Month Momentum % | -97.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:NRXGQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
NephroGenex Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.3 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | -97.5 | ||
| 52-Week Range ($) | 0.0028 - 0.88 | ||
| Shares Outstanding (Mil) | 12.95 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
NephroGenex Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
NephroGenex Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
NephroGenex Inc Frequently Asked Questions
What is NephroGenex Inc(NRXGQ)'s stock price today?
The current price of NRXGQ is $0.00. The 52 week high of NRXGQ is $0.88 and 52 week low is $0.00.
When is next earnings date of NephroGenex Inc(NRXGQ)?
The next earnings date of NephroGenex Inc(NRXGQ) is .
Does NephroGenex Inc(NRXGQ) pay dividends? If so, how much?
NephroGenex Inc(NRXGQ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers